Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : SNY save search
Acer Therapeutics Announces Topline Results from ACER-801 (Osanetant) Phase 2a Trial
Published: 2023-03-17 (Crawled : 13:00) - globenewswire.com
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: -44.55%
H: 0.0%
C: 0.0%
acer-801 topline trial therapeutics results
Press Release: Sanofi cuts U.S. list price of Lantus®, its most-prescribed insulin, by 78% and caps out-of-pocket Lantus costs at $35 for all patients with commercial insurance
Published: 2023-03-16 (Crawled : 21:00) - globenewswire.com
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
lantus commercial insurance sanofi
RNAi Therapeutics Global Market to 2027: Rising Utilization in Oncology Pharmaceuticals and Accelerating Growth Rates of Infectious Diseases Drives Growth
Published: 2023-03-16 (Crawled : 19:00) - prnewswire.com
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
ABUS | $2.75 -0.36% 350K
|
Health Technology
|
| O: 0.34%
H: 3.73%
C: 1.36%
pharmaceuticals global therapeutics growth market
1 in 3 pemphigoid patients not well-managed on current treatments (MARKETVUE® REPORT)
Published: 2023-03-16 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 310
|
Health Technology
|
| O: -0.07%
H: 1.96%
C: 0.56%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 1.01%
H: 0.0%
C: 0.0%
marketvue
IMV Inc. Announces Strategic Update as well as Fourth Quarter and Full Year 2022 Financial and Operational Results
Published: 2023-03-16 (Crawled : 13:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310
|
Health Technology
|
| O: -0.07%
H: 1.96%
C: 0.56%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 1.01%
H: 0.0%
C: 0.0%
IMV | $0.8225 -2.74% 45K
|
Health Technology
|
| O: 0.0%
H: 1.75%
C: -4.42%
year update financial results
Pharming Group reports financial results for full year 2022
Published: 2023-03-16 (Crawled : 07:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 310
|
Health Technology
|
| O: -0.07%
H: 1.96%
C: 0.56%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 1.01%
H: 0.0%
C: 0.0%
year group financial
Innate Pharma Announces Conference Call and Webcast for Full Year 2022 Financial Results
Published: 2023-03-16 (Crawled : 07:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310
|
Health Technology
|
| O: -0.07%
H: 1.96%
C: 0.56%
NVO | News | $126.16 -1.93% -2.24% 3M
|
Health Technology
|
| O: -1.4%
H: 0.03%
C: -0.08%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 1.01%
H: 0.0%
C: 0.0%
IPHA | $2.46 3.8% 4.05% 690
|
Health Technology
|
| O: -6.11%
H: 3.54%
C: 0.69%
pharma conference year financial
Hospital Infection Therapeutics Market to grow at a CAGR of 4.98% from 2022 to 2027, antibiotics to be a major segment for the growth of the market - Technavio
Published: 2023-03-16 (Crawled : 04:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 170
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: 0.0%
SNYNF | News | $94.0 -0.27% -2.18% 310
|
Health Technology
|
| O: -0.07%
H: 1.96%
C: 0.56%
AZNCF | News | $135.35 -3.53% -4.19% 400
|
Health Technology
|
| O: 0.77%
H: 1.14%
C: 0.96%
NVSEF | News | $96.0 0.94% 6.88% 0
|
Health Technology
|
| O: 1.16%
H: 0.73%
C: 0.73%
VTRS | News A | $11.55 1.67% 1.65% 4.4M
|
Health Technology
|
| O: -1.58%
H: 1.93%
C: 1.6%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 0.18%
H: 0.77%
C: 0.64%
GSK | News | $40.86 -0.92% 1.25% 1.6M
|
Health Technology
|
| O: -0.89%
H: 1.64%
C: 1.62%
ABBV | News | $167.8 -1.03% -0.02% 2.9M
|
Health Technology
|
| O: -0.56%
H: 1.78%
C: 1.37%
ABT | News | $106.89 -0.65% -0.09% 4.2M
|
Health Technology
|
| O: -0.76%
H: 2.29%
C: 2.03%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 1.01%
H: 0.0%
C: 0.0%
AZN | News | $71.2 0.49% 0.46% 5.4M
|
Health Technology
|
| O: 0.36%
H: 1.87%
C: 1.81%
infection antibiotics therapeutics growth market
Global Generic Pharmaceuticals Market Report 2023: Major Players Include Teva Pharmaceuticals, Mylan NV, Sandoz International, Hospira and Sun Pharmaceutical
Published: 2023-03-15 (Crawled : 18:00) - prnewswire.com
ENDPQ | News | $0.0007 -50.0% 1K
|
n/a
|
| O: -4.14%
H: 7.45%
C: 4.58%
SNYNF | News | $94.0 -0.27% -2.18% 310
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
NVSEF | News | $96.0 0.94% 6.88% 0
|
Health Technology
|
| O: 2.62%
H: 0.0%
C: -3.57%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: -1.0%
H: 1.39%
C: 1.02%
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: -0.7%
H: 1.34%
C: 0.99%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
report pharmaceuticals global teva market
Protai Adds $12 Million to Seed Round - Bringing the Total to $20 Million - to Build an Oncology Drug Discovery Pipeline
Published: 2023-03-15 (Crawled : 13:20) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 310
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
drug pipeline
Strategy Behind Lowered Insulin Prices: Novo Nordisk and Eli Lilly
Published: 2023-03-15 (Crawled : 13:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
insulin
Seagen to Present New Clinical and Preclinical Data From Broad Portfolio of Targeted Cancer Therapeutics at the 2023 AACR Annual Meeting
Published: 2023-03-14 (Crawled : 23:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310
|
Health Technology
|
| O: -1.13%
H: 0.0%
C: -0.22%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 0.68%
H: 0.55%
C: 0.42%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.08%
H: 0.0%
C: 0.0%
preclinical meeting therapeutics cancer
Verastem Oncology Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Company Progress
Published: 2023-03-14 (Crawled : 23:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310
|
Health Technology
|
| O: -1.13%
H: 0.0%
C: -0.22%
VSTM | $9.31 -3.12% -3.44% 79K
|
Health Technology
|
| O: 0.0%
H: 1.78%
C: -4.44%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.08%
H: 0.0%
C: 0.0%
GERN | $3.58 2.29% 1.96% 5.7M
|
Health Technology
|
| O: 0.75%
H: 4.07%
C: 1.48%
year financial results
Information concerning the total number of voting rights and shares – February 2023
Published: 2023-03-14 (Crawled : 20:00) - globenewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 310
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2022 Financial Results
Published: 2023-03-14 (Crawled : 12:20) - globenewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 310
|
Health Technology
|
| O: -1.13%
H: 0.0%
C: -0.22%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.08%
H: 0.0%
C: 0.0%
COGT | $6.54 -6.03% -6.34% 1.8M
|
Health Technology
|
| O: 1.41%
H: 6.7%
C: 6.05%
business year financial results
AlgoTx Raises €20M to Conduct ATX01’s Phase 2 Program in Peripheral Neuropathic Pain
Published: 2023-03-14 (Crawled : 11:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310
|
Health Technology
|
| O: -1.13%
H: 0.0%
C: -0.22%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.08%
H: 0.0%
C: 0.0%
atx01 program phase 2
Bryn Pharma Announces Appointment of Sandy Loreaux as CEO
Published: 2023-03-13 (Crawled : 20:00) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.81%
H: 0.0%
C: 0.0%
pharma ceo
Accord Healthcare Adds Generic Drug Approved for the Treatment of Relapsing MS
Published: 2023-03-13 (Crawled : 18:00) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.81%
H: 0.0%
C: 0.0%
treatment drug approved
Report Shows Expected Uptick in Layoffs and Collaboration across BioPharma
Published: 2023-03-13 (Crawled : 15:00) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.81%
H: 0.0%
C: 0.0%
biopharma report collaboration expected
Sanofi Bolsters Diabetes Position with $2.9B Provention Buyout
Published: 2023-03-13 (Crawled : 14:00) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.81%
H: 0.0%
C: 0.0%
diabetes sanofi
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
RILY | $29.75 36.97% 27.26% 12M
|
Finance
TROO | $1.41 29.36% 22.14% 7.4M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.